This invention relates to a method of treating disorders responsive to the blockade of sodium ion channels using novel aminoalkyl-substituted aryl compounds of Formula I:
1
or a pharmaceutically-acceptable salt or solvate thereof, wherein n, X, R
1
, R
2
and R
3
are defined in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global or focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of acute or chronic pain, neuropathic pain or surgical pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
本发明涉及使用式I中的新型
氨基烷基取代芳基化合物或其药学上可接受的盐或溶剂的方法,其中n,X,R1,R2和R3在规范中定义,用于治疗对
钠离子通道阻滞有反应的疾病。本发明还涉及使用式I的化合物治疗全球或局部缺血后的神经损伤,治疗或预防神经退行性疾病,如肌萎缩性侧索硬化(ALS),治疗、预防或改善急性或慢性疼痛,神经性疼痛或手术疼痛,作为抗耳鸣剂,抗癫痫药物和抗躁狂抑郁药物,
局部麻醉剂,
抗心律失常药物以及治疗或预防糖尿病神经病变。